Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-invasive respiratory support and prophylactic levetiracetam in children with cerebral malaria and seizures
PACTR202112749708968Phase 1Recruiting
- Sponsor
- Imperial College London
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of levetiracetam in cerebral malaria (CM) and malaria, sponsored by Imperial College London. Primary endpoint: Cumulative time with epileptogenic seizure activity. Started Jan 2019; status: recruiting.
02
Drugs
levetiracetam
03
Conditions
cerebral malaria (CM)malaria
Beyond the preview
Go deeper on PACTR202112749708968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202112749708968.